Complications after radical resection of lung cancer

summary

Clinical practice has proved that not all patients with early lung cancer are in the early stage of the disease by postoperative pathological examination. In nearly 30 years of clinical practice, many imaging findings show that the pathological reports of patients with early stage lung cancer (stage I lung cancer) after thoracotomy, pneumonectomy and hilar mediastinal lymph node dissection are intermediate stage lung cancer (stage II lung cancer) or locally advanced lung cancer (stage III lung cancer). Took a lot of medicine, had been a bit better, looked for expert doctor to treat, the condition got control, about the complication after lung cancer radical operation? Do you know? Today, let me learn about the complications after radical resection of lung cancer.

Complications after radical resection of lung cancer

First: minimally invasive surgery for lung cancer is not very harmful. Whether drug treatment or surgical treatment should be adopted for lung cancer treatment depends on the specific condition of lung cancer. At the same time, the specific conditions of patients themselves should be considered, including the patient's physical endurance, age, gender and so on. Before formulating the treatment policy, we should make a detailed analysis of the specific conditions of patients According to the actual situation to determine the final treatment plan.

Second: the treatment of lung cancer mainly includes surgical treatment, chemotherapy treatment, traditional Chinese medicine treatment, among which surgical treatment is the first choice of lung cancer treatment, minimally invasive surgery is less harmful to patients, surgical treatment is generally applicable to primary early lung cancer, clinical data show that radical surgery for early lung cancer. Surgical treatment for small cell lung cancer with mediastinal lymph node metastasis is very poor, and surgical resection is not recommended. But surgical treatment also has its own disadvantages in it, surgical treatment of early lung cancer is often accompanied by varying degrees of complications, and postoperative recurrence. Early surgical treatment of lung cancer combined with traditional Chinese medicine can enhance the immune function of patients, promote postoperative recovery, and effectively prevent postoperative recurrence and metastasis. Therefore, in the course of treatment of early lung cancer, traditional Chinese medicine is generally used to inhibit tumor metastasis, replication and invasion.

Third: chemotherapy, as the name suggests, is to use some chemical drugs to control the development of tumor cells, in order to achieve the purpose of inhibiting the metastasis and replication of tumor cells. It is mainly used in the treatment of early lung cancer. Generally, after surgery, in order to prevent recurrence of cancer cells, a series of chemotherapy treatment will be carried out to consolidate, but chemotherapy treatment will bring certain adverse reactions to patients, so chemotherapy treatment should also be combined with traditional Chinese medicine to alleviate the adverse reactions of patients.

matters needing attention

Warm tips: fever is one of the main symptoms of lung cancer, patients should be told to keep warm, prevent cold, so as to avoid pneumonia; for irritating cough, antitussive agent can be given; when patients cough at night, hot water can be drunk to reduce the stimulation of throat; In case of hemoptysis, hemostatic drugs should be given. In case of massive hemoptysis, the doctor should be informed immediately. At the same time, the patient's head should be tilted to one side. The accumulated blood in the mouth should be removed in time to prevent asphyxia, and the doctor should be assisted in rescue. Ginsenoside Rh2 can increase the specific and non-specific immune function of cancer patients. It can enhance the patient's physique, improve the disease resistance, reduce the chance of infection, relieve the symptoms of patients with advanced lung cancer, improve the quality of life of patients with advanced lung cancer and prolong their life.